LFG
JANX icon

Larson Financial Group’s Janux Therapeutics JANX Stock Holding History

Larson Financial Group’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.6K Buy
756
+15
+2% +$217 ﹤0.01% 2315
2026
Q1 		$10.3K Buy
741
+497
+204% +$6.82K ﹤0.01% 2236
2025
Q4 		$3.37K Buy
244
+216
+771% +$5.08K ﹤0.01% 2619
2025
Q3 		$684 Buy
28
+22
+367% +$536 ﹤0.01% 3023
2025
Q2 		$139 Hold
6
– – ﹤0.01% 3123
2025
Q1 		$162 Buy
+6
New +$226 ﹤0.01% 2833

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Larson Financial Group's JANX Position: Q2 2026 in Review

Larson Financial Group increased its Janux Therapeutics (JANX) stake by 2% in Q2 2026, buying an estimated $217 and bringing the position to 756 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2315.

Larson Financial Group first reported a position in JANX in Q1 2025 and has held it in 6 quarters since. 198 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Larson Financial Group held 756 shares of Janux Therapeutics worth $11.6K as of Q2 2026.
  • Larson Financial Group bought 15 Janux Therapeutics shares in Q2 2026, an estimated $217.
  • Janux Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2315 holding.
  • Larson Financial Group first reported a position in Janux Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 198 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.